ELDRUG S A has a total of 23 patent applications. Its first patent ever was published in 2007. It filed its patents most often in United Kingdom, Australia and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and biotechnology are OBSCHESTVO S OGRANICHENNOI OTVETSTVENNOSTIYU PHARMENTPR, CONSTELLATION PHARMACEUTICALS INC and ST DI RICERCHE DI BIOLOGIA MOLECOLARE P ANGELETTI SPA.
# | Country | Total Patents | |
---|---|---|---|
#1 | United Kingdom | 6 | |
#2 | Australia | 3 | |
#3 | WIPO (World Intellectual Property Organization) | 3 | |
#4 | China | 2 | |
#5 | EPO (European Patent Office) | 2 | |
#6 | United States | 2 | |
#7 | Brazil | 1 | |
#8 | Canada | 1 | |
#9 | Israel | 1 | |
#10 | Republic of Korea | 1 | |
#11 | Mexico | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry | |
#3 | Biotechnology | |
#4 | Agriculture |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Heterocyclic compounds | |
#3 | Medical preparations | |
#4 | Peptides | |
#5 | Animal care |
# | Name | Total Patents |
---|---|---|
#1 | Matsoukas John | 14 |
#2 | Vlaxakos Dimitrios | 10 |
#3 | Maragoudakis Michael | 10 |
#4 | Apostolopoulos Vasso | 4 |
#5 | Katsara Maria | 4 |
#6 | Grigoriadis Nikos | 3 |
#7 | Lourbopoulos Athanasios | 3 |
#8 | Gavras Charalambos | 3 |
#9 | Tselios Theodoros | 3 |
#10 | Deraos George | 3 |
Publication | Filing date | Title |
---|---|---|
AU2008327638A1 | Peptide analogues and conjugates thereof | |
WO2009016514A2 | 1, 3 and 1, 3, 5 substituted imidazoles as antihypertensiva | |
GB0810553D0 | Peptide analogues and conjugates thereof | |
WO2008142576A2 | 1,(3,)5-substituted imidazoles, their use in the treatment of hypertension and methods for their preparation | |
GB0802405D0 | Therapeutic vaccines | |
GB0801424D0 | Therapeutic vaccines | |
GB0724878D0 | Peptide analogues and conjugates thereof | |
GB0714995D0 | Compounds | |
GB0714603D0 | Compound |